BioRestorative Therapies (BRTX) Projected to Post Earnings on Thursday

BioRestorative Therapies (NASDAQ:BRTX) is projected to post its quarterly earnings results on Thursday, March 27th. Analysts expect BioRestorative Therapies to post earnings of ($0.34) per share and revenue of $0.48 million for the quarter.

BioRestorative Therapies Trading Up 11.9 %

NASDAQ BRTX opened at $1.97 on Tuesday. BioRestorative Therapies has a 12-month low of $1.03 and a 12-month high of $2.55. The company has a fifty day simple moving average of $1.98 and a two-hundred day simple moving average of $1.72. The stock has a market cap of $13.63 million, a P/E ratio of -1.29 and a beta of 64.37.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.